Statins are potent in treatment of MYC-associated HCC by inhibiting HMG-CoA reductase, which facilitates MYC phosphorylation, activation, and hepatocarcinogenesis specifically [23]. The gene discussed is HMGCR; the disease is hepatocellular carcinoma.